{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:47:30Z","timestamp":1791474450949,"version":"4.3.4"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary hyperhidrosis, an idiopathic disease that commonly affects the palms, soles, axillae, or craniofacial region, is characterized by perspiration in excess of what is required for physiologic cooling. This disease begins in childhood or adolescence and negatively impacts emotional, physical, and psychologic well\u2010being. This review explores current therapeutic options for primary hyperhidrosis in the pediatric population, including topical therapies, oral therapies, non\u2010surgical and procedural interventions, and adjunctive therapies. In addition, this review identifies new and emerging treatments and highlights the need for further research and therapeutic options for this impactful disease.<\/jats:p>","DOI":"10.1111\/pde.14551","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T12:12:50Z","timestamp":1614859970000},"page":"561-567","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Primary hyperhidrosis in children: A review of therapeutics"],"prefix":"10.1111","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-7793","authenticated-orcid":false,"given":"Courtney","family":"Remington","sequence":"first","affiliation":[{"name":"The University of Texas Rio Grande Valley School of Medicine  Edinburg TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ruth","sequence":"additional","affiliation":[{"name":"Dell Children\u2019s Medical Group, Pediatric and Adolescent Dermatology  Austin TX USA"},{"name":"Dell Medical School Division of Dermatology The University of Texas at Austin  Austin TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide A.","family":"Hebert","sequence":"additional","affiliation":[{"name":"McGovern Medical School Departments of Dermatology and Pediatrics The University of Texas Health Science Center at Houston  Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"1459","volume-title":"Fitzpatrick\u2019s Dermatology, 9e","author":"Kurta AO","year":"2019"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-016-1697-9"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.001"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04653.x"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.066"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.002"},{"key":"e_1_2_10_8_1","first-page":"3610","volume-title":"Fitzpatrick\u2019s Dermatology, 9e","author":"Kwatra SG","year":"2019"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.14135"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13723"},{"key":"e_1_2_10_11_1","first-page":"57","article-title":"Clinical utility of transdermal delivery of oxybutynin gel via a metered\u2010dose pump in the management of overactive bladder","volume":"4","author":"Wagg A","year":"2012","journal-title":"Res Rep Urol"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13404"},{"key":"e_1_2_10_13_1","volume-title":"Morgan & Mikhail\u2019s Clinical Anesthesiology, 6e","author":"Butterworth JF","year":"2018"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.02.012"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12236"},{"key":"e_1_2_10_16_1","first-page":"149","volume-title":"Goodman & Gilman\u2019s: The pharmacological basis of therapeutics, 13e","author":"Brown JH","year":"2017"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12385"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2016.11.026"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2013.875559"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12620"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00839205"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2011.02250.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-008-9283-y"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2014.06.005"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.02.013"},{"key":"e_1_2_10_26_1","first-page":"769","article-title":"Over a decade of single\u2010center experience with thoracoscopic sympathicolysis for primary palmar hyperhidrosis: a case series","volume":"8","author":"Mol A","year":"2020","journal-title":"Surg Endosc"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.016"},{"key":"e_1_2_10_28_1","unstructured":"Brickell Biotech Announces Approval of Sofpironium Bromide Gel 5% in Japan for Treatment of Primary Axillary Hyperhidrosis Received by its Development Partner Kaken Pharmaceutical | BioSpace. https:\/\/www.biospace.com\/article\/releases\/brickell\u2010biotech\u2010announces\u2010approval\u2010of\u2010sofpironium\u2010bromide\u2010gel\u20105\u2010percent\u2010in\u2010japan\u2010for\u2010treatment\u2010of\u2010primary\u2010axillary\u2010hyperhidrosis\u2010received\u2010by\u2010its\u2010development\u2010partner\u2010kaken\u2010pharmaceutical\/ Accessed September 28 2020."},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14651"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001532"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.14551","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pde.14551","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.14551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T18:24:13Z","timestamp":1693419853000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.14551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1111\/pde.14551"],"URL":"https:\/\/doi.org\/10.1111\/pde.14551","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"2021-03-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}